Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants
Provided By GlobeNewswire
Last update: Feb 5, 2025
-- Advancement to Stage 2 of Infant Study Supported by Review of Stage 1 Safety and Tolerability Data --
Read more at globenewswire.com
